Skip to main content
MYND Life Sciences Inc. logo

MYND Life Sciences Inc. — Investor Relations & Filings

Ticker · MYND LEI · 875500IJJKR27BGAJV75 CSE Professional, scientific and technical activities
Open in API
Filings indexed 130 across all filing types
Latest filing 2025-04-09 Regulatory Filings
Country CA Canada
Listing CSE MYND

About MYND Life Sciences Inc.

https://myndsciences.com/

MYND Life Sciences Inc. is a life sciences-based neuro-pharmaceutical drug development company focused on advancing treatments for mental health and intractable diseases affecting the Central Nervous System (CNS). The company utilizes rigorous science and proprietary technologies to develop precision medicines, primarily leveraging novel psychedelic compounds, including psilocybin, and neuro-anti-inflammatory substances. MYND's core activities involve drug research and development, supported by clinical trials and collaborative research agreements, aimed at creating safe and effective therapeutic solutions.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release disclosing the grant of a management cease trade order under Canadian securities rules due to the company’s inability to file its annual audited financial statements by the filing deadline. It is not the full Annual Report (10-K) or Interim Report, nor is it an earnings release, proxy, or management change announcement. It does not announce a report’s publication (RPA) but is a regulatory update on disclosure defaults under NP 12-203. It falls into the miscellaneous regulatory disclosures category (fallback).
2025-04-09 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press‐style regulatory announcement by MYND Life Sciences regarding a management cease trade order (MCTO) under Canadian securities policy (NP 12-203). It provides an update on filing delays for the annual financial statements and related obligations, but it is not the report itself (e.g., Annual Report, Interim Report), nor does it fit any specialized category (e.g., M&A, Director’s Dealing). It falls under general regulatory announcements and announcements of defaults or trading restrictions. As such, it should be classified as a fallback Regulatory Filing (RNS).
2025-03-25 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing the granting of a management cease trade order (MCTO) due to the company’s delay in filing its annual financial statements and its subsequent default status. It is not an earnings release, share transaction report, or annual report itself, nor is it detailing a board change, financing event, or other specific category. It is a general regulatory announcement about disclosure defaults under Canadian securities law. Therefore, it falls under the fallback category Regulatory Filings (RNS).
2025-03-07 English
News release - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a press release announcing that the Board approved the issuance of 4,000,001 common shares at $0.71/share to settle a CAD 3.5M debenture. This is a notice of new share issuance/capital change rather than a financial report, earnings release, or regulatory filing for an AGM. It fits the definition of a Share Issue/Capital Change announcement (Code: SHA).
2025-01-18 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the successful settlement of a $3.5 million debenture (debt) and the resulting capital structure change, including retirement of the debenture. Although it also notes a CEO transition, the primary focus is on the financing activity and capital structure update. This fits the definition of a Capital/Financing Update (CAP).
2025-01-10 English
News release - English.pdf
Regulatory Filings
2024-11-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.